News FDA clears first migraine DTx from Click Therapeutics Click Therapeutics' digital therapeutic (DTx) for migraine prevention has been cleared by the FDA, becoming the first treatment of its type in the US.
News UK Biobank responds to fears over Chinese access to NHS data Access to de-identified NHS patient data by researchers based in China is not a security concern, according to UK Biobank.
News Why relying on AI outcome models may not be a good idea The use of AI outcome prediction models (OPMs) in medicine is on the rise, but a new paper has warned widespread use could lead to patient harm.
News EVERSANA adds AI to medical, legal and regulatory reviews A new AI-powered solution from EVERSANA aims to take the pain out of medical, legal and regulatory (MLR) reviews.
News FDA nod broadens use of Brainomix's stroke AI Brainomix has been granted FDA approval for a new feature for its AI-powered stroke imaging software that could unlock wider use in the US.
News UK unveils £600m investment in health data research The UK government and Wellcome Trust will invest £600m in a Health Data Research Service to unlock the power of NHS patient data for medical research.
Market Access Sanofi's Dupixent gets FDA nod for chronic hives indication Dupixent's seventh indication is chronic hives, where a new treatment hasn't been approved since Novartis's Xolair in 2014
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl